Evgen Pharma (EVG): Corp Full-year results – await SAH Phase IIb data | Iofina (IOF): Corp CBD oil licence approved | Sopheon (SPE): Corp AGM statement | Taptica (TAP): Corp Integration on track as Performance division struggles | Tekcapital (TEK): Corp Follow-on order for MicroSalt® | Zambeef (ZAM): Corp Performing despite unhelpful macro environment
13 Jun 2019
Morning Note – 13 June 2019
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Morning Note – 13 June 2019
Nexxen International Ltd. (NEXN:LON), 211 | Zambeef Products PLC (ZAM:LON), 5.8 | Evgen Pharma Plc (EVG:LON), 0.9
- Published:
13 Jun 2019 -
Author:
Andrew Darley | Mark Paddon | Mark Brewer | Jonathan Wright | Michael Clifton | Cavendish Research -
Pages:
9
Evgen Pharma (EVG): Corp Full-year results – await SAH Phase IIb data | Iofina (IOF): Corp CBD oil licence approved | Sopheon (SPE): Corp AGM statement | Taptica (TAP): Corp Integration on track as Performance division struggles | Tekcapital (TEK): Corp Follow-on order for MicroSalt® | Zambeef (ZAM): Corp Performing despite unhelpful macro environment